Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

Atherosclerosis

Volumn 158, Issue 2, 2001, Pages 425-430

  Yoo, Jun Hyun ^a   Lee, Sung Chang ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

Asymmetric dimethylarginine; Homocyst(e)ine; Nitric oxide synthase; Stroke; The elderly

Indexed keywords

HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0034813226     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00444-0     Document Type: Article

References (39)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor
3. Endothelial dysfunction: Does it matter? Is it reversible?
4. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
5. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor
6. Nitric oxide: An endogenous modulator of leukocyte adhesion
7. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
8. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans
9. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects related to coronary risk factors and their interaction
10. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
11. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
12. Antiatherosclerotic effects of L-arginine in the hypercholesterolemic rabbit
13. The L-arginine-nitric oxide pathway
14. Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure
15. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits
16. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits
17. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction - Its role in hypercholesterolemia
18. Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis
19. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycemia
20. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerosis
21. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease
22. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women
23. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine
24. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits
25. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production
26. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice
27. Regression or progression: Dependency on vascular nitric oxide
28. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis
29. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
30. Determination of dimethylated arginines in human plasma by high-performance liquld chromatography
31. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase
32. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules
33. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells
34. Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
35. Metabolism of methylarginines by human vasculature: Implications for the regulation of nitric oxide synthesis
36. Regulation of nitric oxide synthesis by dimethylargine dimethylaminohydrolase
37. Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase
38. G-dimethylarginine by human endothelial cells
39. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease